Trident Lifeline has entered into a strategic alliance with National Institutes of Pharmaceutical Education and Research- Ahmedabad (NIPER-A) regarding the technology transfer of Vorinostat- one of the crucial medications for treating Cutaneous T-Cell Lymphoma (CTCL), a rare blood originated skin cancer which is currently unavailable in India. This collaboration aims to revolutionize the treatment landscape for CTCL patients by providing access to a high-quality, domestically produced Vorinostat.
The company will scale up the production of Vorinostat and introduce it to the Indian market by leveraging NIPER Ahmedabad's expertise. Furthermore, as a part of CSR initiative, the company aims to provide Vorinostat free of charge to economically disadvantaged patients.
Trident Lifeline is engaged in the pharmaceutical business ethical marketing in domestic as well as international market.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1735.45 |
Dr. Reddys Lab | 1144.05 |
Cipla | 1441.70 |
Lupin | 2026.50 |
Zydus Lifesciences | 885.70 |
View more.. |